FC
Foresite Capital Management V, LLC
WEST HOLLYWOOD CA · SEC CIK 0001792206
$362.20M2026Q2 reported value
9Positions
100.0%Top 10 weight · largest 45.8%
0 / 1New / sold out
26Q126Q2
Top 10 holdings % of portfolio
2026Q2 top buys estimated at quarter-end value
PHVS Added+$16.25M
CGON Added+$5.33M
2026Q2 top sells estimated at quarter-end value
MAZE Sold out-$773,264
LYEL Reduced-$9,723
2026Q2 holdings click a header to sort
Export CSV 🔒| Ticker | Name | Value ▼ | Weight | Shares | Share change | Change | Est. flow | Action |
|---|---|---|---|---|---|---|---|---|
| ALMS | ALUMIS INC. | $165.94M | 45.81% | 5,896,995 | 0 | 0.0% | — | Unchanged |
| CGON | CG Oncology, Inc. | $76.67M | 21.17% | 1,079,050 | 75,000 | 7.5% | $5.33M | Added |
| IRON | Disc Medicine, Inc. | $27.36M | 7.55% | 374,069 | 0 | 0.0% | — | Unchanged |
| HIMS | Hims & Hers Health, Inc. | $25.59M | 7.07% | 738,151 | 0 | 0.0% | — | Unchanged |
| PHVS | Pharvaris N.V. | $22.97M | 6.34% | 664,142 | 470,017 | 242.1% | $16.25M | Added |
| EIKN | Eikon Therapeutics, Inc. | $17.21M | 4.75% | 1,318,983 | 0 | 0.0% | — | Unchanged |
| ODTX | Odyssey Therapeutics, Inc. | $13.34M | 3.68% | 713,105 | 713,105 | — | — | First reported |
| LYEL | Lyell Immunopharma, Inc. | $6.69M | 1.85% | 476,386 | -692 | -0.1% | -$9,723 | Reduced |
| NRIX | Nurix Therapeutics, Inc. | $6.43M | 1.77% | 265,000 | 0 | 0.0% | — | Unchanged |
| MAZE | Maze Therapeutics, Inc. | $0 | 0.00% | 0 | -25,905 | -100.0% | -$773,264 | Sold out |